{"Q": 1, "answer": "no", "rationale": "The segment describes a vaccine deal but contains no intensifier or comparative modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_6708", "batch_size": 200, "batch_pos": 15, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "The segment does not contain any high-potency verbs, potent metaphors, superlatives + harm nouns, intensifiers + harm nouns, or critical alert phrases.", "method": "llm_batch", "batch_id": "batch_2_15640", "batch_size": 200, "batch_pos": 2, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "No moderate verb or scale related to outbreak impact.", "method": "llm_batch", "batch_id": "batch_3_17620", "batch_size": 200, "batch_pos": 144, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
